Receptor — Beta-adrenergic

Recent, high-impact research (2023–2025) has moved beyond basic cardiovascular signaling, focusing on deep molecular insights into receptor structure, cancer metastasis, and developmental biology. 1. Advanced Structural and Functional Insights (2025) Distinct types of β1beta sub 1 β2beta sub 2 β3beta sub 3 ) are organized in specific cardiac zones. β1beta sub 1

-ARs are key regulators in embryonic development. They modulate actomyosin relaxation, allowing epithelial tissues to stretch during body elongation, as detailed in Cell.com . 4. Summary of Subtype Characteristics Primary Location Key Physiological Effect β1beta sub 1 Heart, Adipose tissue Increases heart rate & contractility β2beta sub 2 Smooth muscle (Airways), Immune Cells Bronchodilation, Vasodilation β3beta sub 3 Adipose tissue, Urinary bladder Lipolysis, Thermogenesis beta-adrenergic receptor

-ARs exist inside neurons—not just on the surface—where they bind norepinephrine and activate downstream pathways that regulate synaptic strength, such as AMPA receptor phosphorylation. β1beta sub 1 -ARs are key regulators in

-AR activation) increases cancer cell stiffness, enhancing mobility and promoting metastasis. Studies have shown that blocking ARs can attenuate lung metastasis in various cancer models. β2beta sub 2

( -ARs) are a class of G protein-coupled receptors (GPCRs) that act as key molecular targets in the sympathetic nervous system, primarily activated by catecholamines like adrenaline and noradrenaline to manage "fight or flight" responses.

Emerging research shows that β2beta sub 2

Contrary to their primary role in the adult nervous system, β2beta sub 2